Frequently Asked Questions about Pharmacological Reviews
This page provides information for librarians, readers, and authors. If we have not anticipated your question, please contact us.
| GENERAL | CONTENT | ACCESS CONTROL |
GENERAL
Pharmacological Reviews is a peer-reviewed journal that presents important review articles covering the broad spectrum of pharmacological research. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nonmenclature reports are published here. Pharmacological Reviews has the second highest impact factor of the Science Citation Index's pharmacy and pharmacology journals (2018) and a cited half-life of >10.
Pharmacological Reviews is archived in CLOCKSS.
How do I contact the journal for subscription information?
See ASPET Journals Subscriber Help and Services.
Who is the publisher?
The American Society for Pharmacology and Experimental Therapeutics, a nonprofit scientific society founded in 1908.
What is the publisher’s home page?
What is the main URL for the journal site?
http://pharmrev.aspetjournals.org
What is the URL for use from these locations: Australia, Brazil, China, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Mexico, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, The Netherlands, and the United Kingdom?
See http://intl-pharmrev.aspetjournals.org
What is the online ISSN number?
1521-0081
What is the print ISSN number?
0031-6997 – Please note: Pharmacological Reviews moved to online-only publication in 2012.
What are the Terms and Conditions for use of the journal’s website?
See http://aspetjournals.org/content/terms.
Do individuals and institutions have permission to make links directly to pages within the journal’s site?
Yes.
What organization is editorially responsible for the journal?
The American Society for Pharmacology and Experimental Therapeutics.
| GENERAL | CONTENT | ACCESS CONTROL |
CONTENT
Are URLs for content in the journal stable (i.e., persistent)?
Yes.
Which ISI categories is the journal in?
Pharmacology and Pharmacy
What is the ISI Impact Factor?
19.3 for 2023
How many issues are currently published each year?
6 issues (January, March, May, July, September, and November) starting in 2023. Please note that ASPET’s journals are published continuously. Articles are organized by issue but are posted online as soon as they are ready.
Does the journal deposit its content in CrossRef?
Yes. Content has been deposited since 2001, volume 53. All articles published since 2003 have a DOI. The DOI prefix/publisher ID is 10.1124.
What is the range of content online?
Earliest full-text PDF date: April 1, 1949 (volume 1, issue 1)
Earliest full-text HTML date: March 1, 1997 (volume 51, issue 1)
Are there free back issues?
ASPET makes all content freely accessible 12 months after publication. It remains freely accessible for 5 years. Subscriptions include access to all content back to volume 1, issue 1.
| GENERAL | CONTENT | ACCESS CONTROL |
ACCESS CONTROL
What is the cost of an online subscription?
See our subscription price page.
Is institutional access limited to libraries only? To selected computers only?
Institutional access is allowed throughout an institution's facility or campus with no limit on concurrent users. Remote access through a proxy server is allowed if users are authenticated. Off campus use is also enabled by Google Scholar CASA (Campus Activated Subscriber Access) tokens. Information about CASA is here. Institutions, however, must subscribe at the appropriate subscription tier.
Do institutions have access to all content, or does it exclude certain content types such as PDFs?
All content and features are included with a subscription.
Does the site allow access via institutional subscriptions?
Yes.
Is the use of authenticated user IP addresses allowed for granting access to off-campus users?
Yes. Off campus use is also enabled by Google Scholar CASA (Campus Activated Subscriber Access) tokens. Information about CASA is here.
Is there free access for developing countries?
Yes. ASPET’s journals participate in Research4Life.
How does my institution subscribe?
See ASPET Journals Subscriber Help and Services.
Can individuals pay for limited site access?
Yes. ASPET offers a pay-per-view option for all content.
Is interlibrary loan allowed using the online version?
Yes.